Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Artificial Joint Infection Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Aminoglycosides
1.2.3 Glycopeptides
1.2.4 Rifamycin
1.2.5 Lincosamide
1.2.6 Penicillin
1.2.7 Others
1.3 Market by Application
1.3.1 Global Artificial Joint Infection Treatment Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Artificial Joint Infection Treatment Market Perspective (2018-2029)
2.2 Artificial Joint Infection Treatment Growth Trends by Region
2.2.1 Global Artificial Joint Infection Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Artificial Joint Infection Treatment Historic Market Size by Region (2018-2024)
2.2.3 Artificial Joint Infection Treatment Forecasted Market Size by Region (2024-2029)
2.3 Artificial Joint Infection Treatment Market Dynamics
2.3.1 Artificial Joint Infection Treatment Industry Trends
2.3.2 Artificial Joint Infection Treatment Market Drivers
2.3.3 Artificial Joint Infection Treatment Market Challenges
2.3.4 Artificial Joint Infection Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Artificial Joint Infection Treatment Players by Revenue
3.1.1 Global Top Artificial Joint Infection Treatment Players by Revenue (2018-2024)
3.1.2 Global Artificial Joint Infection Treatment Revenue Market Share by Players (2018-2024)
3.2 Global Artificial Joint Infection Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Artificial Joint Infection Treatment Revenue
3.4 Global Artificial Joint Infection Treatment Market Concentration Ratio
3.4.1 Global Artificial Joint Infection Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Artificial Joint Infection Treatment Revenue in 2022
3.5 Artificial Joint Infection Treatment Key Players Head office and Area Served
3.6 Key Players Artificial Joint Infection Treatment Product Solution and Service
3.7 Date of Enter into Artificial Joint Infection Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Artificial Joint Infection Treatment Breakdown Data by Type
4.1 Global Artificial Joint Infection Treatment Historic Market Size by Type (2018-2024)
4.2 Global Artificial Joint Infection Treatment Forecasted Market Size by Type (2024-2029)
5 Artificial Joint Infection Treatment Breakdown Data by Application
5.1 Global Artificial Joint Infection Treatment Historic Market Size by Application (2018-2024)
5.2 Global Artificial Joint Infection Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Artificial Joint Infection Treatment Market Size (2018-2029)
6.2 North America Artificial Joint Infection Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Artificial Joint Infection Treatment Market Size by Country (2018-2024)
6.4 North America Artificial Joint Infection Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Artificial Joint Infection Treatment Market Size (2018-2029)
7.2 Europe Artificial Joint Infection Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Artificial Joint Infection Treatment Market Size by Country (2018-2024)
7.4 Europe Artificial Joint Infection Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Artificial Joint Infection Treatment Market Size (2018-2029)
8.2 Asia-Pacific Artificial Joint Infection Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Artificial Joint Infection Treatment Market Size by Region (2018-2024)
8.4 Asia-Pacific Artificial Joint Infection Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Artificial Joint Infection Treatment Market Size (2018-2029)
9.2 Latin America Artificial Joint Infection Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Artificial Joint Infection Treatment Market Size by Country (2018-2024)
9.4 Latin America Artificial Joint Infection Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Artificial Joint Infection Treatment Market Size (2018-2029)
10.2 Middle East & Africa Artificial Joint Infection Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Artificial Joint Infection Treatment Market Size by Country (2018-2024)
10.4 Middle East & Africa Artificial Joint Infection Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Arrevus
11.1.1 Arrevus Company Detail
11.1.2 Arrevus Business Overview
11.1.3 Arrevus Artificial Joint Infection Treatment Introduction
11.1.4 Arrevus Revenue in Artificial Joint Infection Treatment Business (2018-2024)
11.1.5 Arrevus Recent Development
11.2 MELINTA THERAPEUTICS, INC.
11.2.1 MELINTA THERAPEUTICS, INC. Company Detail
11.2.2 MELINTA THERAPEUTICS, INC. Business Overview
11.2.3 MELINTA THERAPEUTICS, INC. Artificial Joint Infection Treatment Introduction
11.2.4 MELINTA THERAPEUTICS, INC. Revenue in Artificial Joint Infection Treatment Business (2018-2024)
11.2.5 MELINTA THERAPEUTICS, INC. Recent Development
11.3 Nabriva Therapeutics plc
11.3.1 Nabriva Therapeutics plc Company Detail
11.3.2 Nabriva Therapeutics plc Business Overview
11.3.3 Nabriva Therapeutics plc Artificial Joint Infection Treatment Introduction
11.3.4 Nabriva Therapeutics plc Revenue in Artificial Joint Infection Treatment Business (2018-2024)
11.3.5 Nabriva Therapeutics plc Recent Development
11.4 Peptilogics
11.4.1 Peptilogics Company Detail
11.4.2 Peptilogics Business Overview
11.4.3 Peptilogics Artificial Joint Infection Treatment Introduction
11.4.4 Peptilogics Revenue in Artificial Joint Infection Treatment Business (2018-2024)
11.4.5 Peptilogics Recent Development
11.5 Telephus Medical LLC
11.5.1 Telephus Medical LLC Company Detail
11.5.2 Telephus Medical LLC Business Overview
11.5.3 Telephus Medical LLC Artificial Joint Infection Treatment Introduction
11.5.4 Telephus Medical LLC Revenue in Artificial Joint Infection Treatment Business (2018-2024)
11.5.5 Telephus Medical LLC Recent Development
11.6 TenNor Therapeutics Ltd
11.6.1 TenNor Therapeutics Ltd Company Detail
11.6.2 TenNor Therapeutics Ltd Business Overview
11.6.3 TenNor Therapeutics Ltd Artificial Joint Infection Treatment Introduction
11.6.4 TenNor Therapeutics Ltd Revenue in Artificial Joint Infection Treatment Business (2018-2024)
11.6.5 TenNor Therapeutics Ltd Recent Development
11.7 Cempra Inc
11.7.1 Cempra Inc Company Detail
11.7.2 Cempra Inc Business Overview
11.7.3 Cempra Inc Artificial Joint Infection Treatment Introduction
11.7.4 Cempra Inc Revenue in Artificial Joint Infection Treatment Business (2018-2024)
11.7.5 Cempra Inc Recent Development
11.8 Motif Bio Plc
11.8.1 Motif Bio Plc Company Detail
11.8.2 Motif Bio Plc Business Overview
11.8.3 Motif Bio Plc Artificial Joint Infection Treatment Introduction
11.8.4 Motif Bio Plc Revenue in Artificial Joint Infection Treatment Business (2018-2024)
11.8.5 Motif Bio Plc Recent Development
11.9 Johnson & Johnson Services
11.9.1 Johnson & Johnson Services Company Detail
11.9.2 Johnson & Johnson Services Business Overview
11.9.3 Johnson & Johnson Services Artificial Joint Infection Treatment Introduction
11.9.4 Johnson & Johnson Services Revenue in Artificial Joint Infection Treatment Business (2018-2024)
11.9.5 Johnson & Johnson Services Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Artificial Joint Infection Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Aminoglycosides
Table 3. Key Players of Glycopeptides
Table 4. Key Players of Rifamycin
Table 5. Key Players of Lincosamide
Table 6. Key Players of Penicillin
Table 7. Key Players of Others
Table 8. Global Artificial Joint Infection Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Artificial Joint Infection Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 10. Global Artificial Joint Infection Treatment Market Size by Region (2018-2024) & (US$ Million)
Table 11. Global Artificial Joint Infection Treatment Market Share by Region (2018-2024)
Table 12. Global Artificial Joint Infection Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 13. Global Artificial Joint Infection Treatment Market Share by Region (2024-2029)
Table 14. Artificial Joint Infection Treatment Market Trends
Table 15. Artificial Joint Infection Treatment Market Drivers
Table 16. Artificial Joint Infection Treatment Market Challenges
Table 17. Artificial Joint Infection Treatment Market Restraints
Table 18. Global Artificial Joint Infection Treatment Revenue by Players (2018-2024) & (US$ Million)
Table 19. Global Artificial Joint Infection Treatment Market Share by Players (2018-2024)
Table 20. Global Top Artificial Joint Infection Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Joint Infection Treatment as of 2022)
Table 21. Ranking of Global Top Artificial Joint Infection Treatment Companies by Revenue (US$ Million) in 2022
Table 22. Global 5 Largest Players Market Share by Artificial Joint Infection Treatment Revenue (CR5 and HHI) & (2018-2024)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Artificial Joint Infection Treatment Product Solution and Service
Table 25. Date of Enter into Artificial Joint Infection Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Artificial Joint Infection Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 28. Global Artificial Joint Infection Treatment Revenue Market Share by Type (2018-2024)
Table 29. Global Artificial Joint Infection Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 30. Global Artificial Joint Infection Treatment Revenue Market Share by Type (2024-2029)
Table 31. Global Artificial Joint Infection Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 32. Global Artificial Joint Infection Treatment Revenue Market Share by Application (2018-2024)
Table 33. Global Artificial Joint Infection Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 34. Global Artificial Joint Infection Treatment Revenue Market Share by Application (2024-2029)
Table 35. North America Artificial Joint Infection Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Artificial Joint Infection Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 37. North America Artificial Joint Infection Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Artificial Joint Infection Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 39. Europe Artificial Joint Infection Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 40. Europe Artificial Joint Infection Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 41. Asia-Pacific Artificial Joint Infection Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 42. Asia-Pacific Artificial Joint Infection Treatment Market Size by Region (2018-2024) & (US$ Million)
Table 43. Asia-Pacific Artificial Joint Infection Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 44. Latin America Artificial Joint Infection Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Latin America Artificial Joint Infection Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 46. Latin America Artificial Joint Infection Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 47. Middle East & Africa Artificial Joint Infection Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 48. Middle East & Africa Artificial Joint Infection Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Artificial Joint Infection Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 50. Arrevus Company Detail
Table 51. Arrevus Business Overview
Table 52. Arrevus Artificial Joint Infection Treatment Product
Table 53. Arrevus Revenue in Artificial Joint Infection Treatment Business (2018-2024) & (US$ Million)
Table 54. Arrevus Recent Development
Table 55. MELINTA THERAPEUTICS, INC. Company Detail
Table 56. MELINTA THERAPEUTICS, INC. Business Overview
Table 57. MELINTA THERAPEUTICS, INC. Artificial Joint Infection Treatment Product
Table 58. MELINTA THERAPEUTICS, INC. Revenue in Artificial Joint Infection Treatment Business (2018-2024) & (US$ Million)
Table 59. MELINTA THERAPEUTICS, INC. Recent Development
Table 60. Nabriva Therapeutics plc Company Detail
Table 61. Nabriva Therapeutics plc Business Overview
Table 62. Nabriva Therapeutics plc Artificial Joint Infection Treatment Product
Table 63. Nabriva Therapeutics plc Revenue in Artificial Joint Infection Treatment Business (2018-2024) & (US$ Million)
Table 64. Nabriva Therapeutics plc Recent Development
Table 65. Peptilogics Company Detail
Table 66. Peptilogics Business Overview
Table 67. Peptilogics Artificial Joint Infection Treatment Product
Table 68. Peptilogics Revenue in Artificial Joint Infection Treatment Business (2018-2024) & (US$ Million)
Table 69. Peptilogics Recent Development
Table 70. Telephus Medical LLC Company Detail
Table 71. Telephus Medical LLC Business Overview
Table 72. Telephus Medical LLC Artificial Joint Infection Treatment Product
Table 73. Telephus Medical LLC Revenue in Artificial Joint Infection Treatment Business (2018-2024) & (US$ Million)
Table 74. Telephus Medical LLC Recent Development
Table 75. TenNor Therapeutics Ltd Company Detail
Table 76. TenNor Therapeutics Ltd Business Overview
Table 77. TenNor Therapeutics Ltd Artificial Joint Infection Treatment Product
Table 78. TenNor Therapeutics Ltd Revenue in Artificial Joint Infection Treatment Business (2018-2024) & (US$ Million)
Table 79. TenNor Therapeutics Ltd Recent Development
Table 80. Cempra Inc Company Detail
Table 81. Cempra Inc Business Overview
Table 82. Cempra Inc Artificial Joint Infection Treatment Product
Table 83. Cempra Inc Revenue in Artificial Joint Infection Treatment Business (2018-2024) & (US$ Million)
Table 84. Cempra Inc Recent Development
Table 85. Motif Bio Plc Company Detail
Table 86. Motif Bio Plc Business Overview
Table 87. Motif Bio Plc Artificial Joint Infection Treatment Product
Table 88. Motif Bio Plc Revenue in Artificial Joint Infection Treatment Business (2018-2024) & (US$ Million)
Table 89. Motif Bio Plc Recent Development
Table 90. Johnson & Johnson Services Company Detail
Table 91. Johnson & Johnson Services Business Overview
Table 92. Johnson & Johnson Services Artificial Joint Infection Treatment Product
Table 93. Johnson & Johnson Services Revenue in Artificial Joint Infection Treatment Business (2018-2024) & (US$ Million)
Table 94. Johnson & Johnson Services Recent Development
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Artificial Joint Infection Treatment Market Size Comparison by Type (2024-2029) & (US$ Million)
Figure 2. Global Artificial Joint Infection Treatment Market Share by Type: 2022 VS 2029
Figure 3. Aminoglycosides Features
Figure 4. Glycopeptides Features
Figure 5. Rifamycin Features
Figure 6. Lincosamide Features
Figure 7. Penicillin Features
Figure 8. Others Features
Figure 9. Global Artificial Joint Infection Treatment Market Size Comparison by Application (2024-2029) & (US$ Million)
Figure 10. Global Artificial Joint Infection Treatment Market Share by Application: 2022 VS 2029
Figure 11. Hospital Case Studies
Figure 12. Clinic Case Studies
Figure 13. Others Case Studies
Figure 14. Artificial Joint Infection Treatment Report Years Considered
Figure 15. Global Artificial Joint Infection Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 16. Global Artificial Joint Infection Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Artificial Joint Infection Treatment Market Share by Region: 2022 VS 2029
Figure 18. Global Artificial Joint Infection Treatment Market Share by Players in 2022
Figure 19. Global Top Artificial Joint Infection Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Joint Infection Treatment as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Artificial Joint Infection Treatment Revenue in 2022
Figure 21. North America Artificial Joint Infection Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. North America Artificial Joint Infection Treatment Market Share by Country (2018-2029)
Figure 23. United States Artificial Joint Infection Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Artificial Joint Infection Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Artificial Joint Infection Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Artificial Joint Infection Treatment Market Share by Country (2018-2029)
Figure 27. Germany Artificial Joint Infection Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Artificial Joint Infection Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Artificial Joint Infection Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Artificial Joint Infection Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Artificial Joint Infection Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Artificial Joint Infection Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Artificial Joint Infection Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Asia-Pacific Artificial Joint Infection Treatment Market Share by Region (2018-2029)
Figure 35. China Artificial Joint Infection Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Japan Artificial Joint Infection Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. South Korea Artificial Joint Infection Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Southeast Asia Artificial Joint Infection Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. India Artificial Joint Infection Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Australia Artificial Joint Infection Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Artificial Joint Infection Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Latin America Artificial Joint Infection Treatment Market Share by Country (2018-2029)
Figure 43. Mexico Artificial Joint Infection Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Brazil Artificial Joint Infection Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Artificial Joint Infection Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Artificial Joint Infection Treatment Market Share by Country (2018-2029)
Figure 47. Turkey Artificial Joint Infection Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Saudi Arabia Artificial Joint Infection Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Arrevus Revenue Growth Rate in Artificial Joint Infection Treatment Business (2018-2024)
Figure 50. MELINTA THERAPEUTICS, INC. Revenue Growth Rate in Artificial Joint Infection Treatment Business (2018-2024)
Figure 51. Nabriva Therapeutics plc Revenue Growth Rate in Artificial Joint Infection Treatment Business (2018-2024)
Figure 52. Peptilogics Revenue Growth Rate in Artificial Joint Infection Treatment Business (2018-2024)
Figure 53. Telephus Medical LLC Revenue Growth Rate in Artificial Joint Infection Treatment Business (2018-2024)
Figure 54. TenNor Therapeutics Ltd Revenue Growth Rate in Artificial Joint Infection Treatment Business (2018-2024)
Figure 55. Cempra Inc Revenue Growth Rate in Artificial Joint Infection Treatment Business (2018-2024)
Figure 56. Motif Bio Plc Revenue Growth Rate in Artificial Joint Infection Treatment Business (2018-2024)
Figure 57. Johnson & Johnson Services Revenue Growth Rate in Artificial Joint Infection Treatment Business (2018-2024)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed